As an oncogene, MYC is frequently deregulated across various cancer types, including breast cancer, liver cancer, colorectal carcinoma, multiple myeloma, and lymphomas, frequently inducing a dependency on the oncogene for disease progression.1, 2, 3, 4, 5, 6. This evidence concerns the gene MYC and cancer.